Pacific Biosciences (NasdaqGS:PACB) Q1 2026 Earnings call May 07, 2026 04:30 PM ET Company Participants Christian Henry - President and CEO Jim Gibson - CFO Kayleen Parrish - Investor Relations Conference Call Participants Austin Moeller - Analyst Mason Carrico - Research Analyst Peron Patel - Analyst Philip Nadeau - Analyst None - Analyst Operator Welcome to the PacBio first quarter 2026 earnings conference call. I would now like to turn the conference over to Kayleen Parrish with Investor Relations. Pleas ...

Pacific Biosciences (NasdaqGS:PACB) Q1 2026 Earnings call May 07, 2026 04:30 PM ET Speaker6Welcome to the PacBio first quarter 2026 earnings conference call. I would now like to turn the conference over to Kayleen Parrish with Investor Relations. Please go ahead.Speaker4Good afternoon, and welcome to PacBio's first quarter 2026 earnings conference call. Earlier today, we issued a press release outlining the financial results we'll be discussing on today's call, a copy of which is available on the Investors ...

MENLO PARK, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2026. Recent Business Highlights Selected by Basecamp Research to power its Trillion Gene Atlas, which is expected to result in approximately 100,000 samples being deeply sequenced from over 31 countriesAnnounced a collaboration with DNAstack to power the first global federated HiFi whole genome datasetExpanded SPRQ-Nx beta program to more customers domestically and in ...